Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, previously known as BIIB037, constitutes a complex effort to treat early-stage Alzheimer's disease. Created by Biogen, aducanumab acts by removing https://donnaqsfw351987.mpeblog.com/74647483/text